$3.29
7.32%
Nasdaq, Fri, Dec 27 2024
ISIN
US05344R1041
Symbol
AVCO

Avalon GloboCare Corp. Stock price

$3.29
+0.49 17.50% 1M
-4.06 55.24% 6M
-3.96 54.59% YTD
-3.89 54.17% 1Y
-151.21 97.87% 3Y
-293.71 98.89% 5Y
-101.71 96.87% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.26 7.32%
ISIN
US05344R1041
Symbol
AVCO

Key metrics

Market capitalization $3.60m
Enterprise Value $31.29m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 23.89
P/S ratio (TTM) P/S ratio 2.75
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 6.36%
Revenue (TTM) Revenue $1.31m
EBIT (operating result TTM) EBIT $-3.80m
Free Cash Flow (TTM) Free Cash Flow $-4.62m
Cash position $1.02m
EPS (TTM) EPS $-3.03
Short interest 1.05%
Show more

Is Avalon GloboCare Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Financial data from Avalon GloboCare Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1.31 1.31
7% 7%
100%
- Direct Costs 1.07 1.07
4% 4%
82%
0.24 0.24
20% 20%
18%
- Selling and Administrative Expenses 3.78 3.78
53% 53%
289%
- Research and Development Expense -0.04 -0.04
113% 113%
-3%
-3.50 -3.50
57% 57%
-267%
- Depreciation and Amortization 0.30 0.30
19% 19%
23%
EBIT (Operating Income) EBIT -3.80 -3.80
56% 56%
-290%
Net Profit -15 -15
60% 60%
-1,124%

In millions USD.

Don't miss a Thing! We will send you all news about Avalon GloboCare Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and provision of healthcare services. It operates through the following segments: Real Property Operating; Medical Related Consulting Services; and Development Services and Sales of Developed Products. It offers regenerative medicine, cell-based immunotherapy, exosome technology, and rehabilitation medicine through Avalon Cell and Avalon Rehab platforms. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.

Head office United States
CEO David Jin
Employees 5
Founded 2014
Website www.avalon-globocare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today